Evidence map›Paper›PMID 23680702›Full record

ReviewNeuroscience and biobehavioral reviews2013

Using conditioned place preference to identify relapse prevention medications.

T Celeste Napier, Amy A Herrold, Harriet de Wit

Abstract readReview
In one paragraph

Review in Neuroscience and biobehavioral reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Review
  2. Article
  3. Context features influence alcohol reward and motivation.Alcohol, clinical & experimental research · 2026
    Article
  4. dCA1 cells encode and update contextual place preference.Frontiers in systems neuroscience · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. VR for Studying the Neuroscience of Emotional Responses.Current topics in behavioral neurosciences · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

T Celeste NapierDepartment of Pharmacology and Center for Compulsive Behaviors and Addiction, Rush University, Chicago, IL, United States. Electronic address: celeste_napier@rush.edu.
Amy A Herrold
Harriet de Wit

Funding

Determinants of Drug Preference in Humans--Administrative SupplementR01DA002812 · NIDA · UNIVERSITY OF CHICAGO · PI DE WIT, HARRIET · 1985 to 2024
$10.6M
Acquisition and persistence of drug cue conditioning in humans - Resubmission 01R01DA037011 · NIDA · UNIVERSITY OF CHICAGO · PI DE WIT, HARRIET · 2014 to 2018
$2.3M
5-HT &Medication Development for Methamphetamine AbuseR01DA015760 · NIDA · RUSH UNIVERSITY MEDICAL CENTER · PI NAPIER, T. CELESTE · 2003 to 2007
$1.7M
5HT receptors, neuronal plasticity, and methamphetamine-induced place perference.F31DA024923 · NIDA · RUSH UNIVERSITY MEDICAL CENTER · PI GRAVES, STEVEN MICHAEL · 2009 to 2011
$108k
GABABeta Regulation of METH-Induced Associative LearningF31DA021475 · NIDA · LOYOLA UNIVERSITY CHICAGO · PI VOIGT-ZUWALA, ROBIN M · 2007 to 2009
$77k
mGluR5 Regulation of METH Reward and Sensorimotor GatingF31DA023306 · NIDA · LOYOLA UNIVERSITY CHICAGO · PI HERROLD, AMY · 2007 to 2009
$75k
Cellular Mechanisms in Opiate Reward-Mediated LearningF31DA019783 · NIDA · LOYOLA UNIVERSITY CHICAGO · PI PERSONS, AMANDA LEE · 2006 to 2008
$73k
NIDA NIH HHS DA015760NIDA NIH HHS DA019783NIDA NIH HHS DA021475NIDA NIH HHS DA023306NIDA NIH HHS DA024923NIDA NIH HHS DA02812NIDA NIH HHS F31 DA019783NIDA NIH HHS F31 DA021475NIDA NIH HHS F31 DA023306NIDA NIH HHS F31 DA024923NIDA NIH HHS R01 DA002812NIDA NIH HHS R01 DA015760NIDA NIH HHS R01 DA037011
6 · The paper itself

Abstract

Stimuli, including contexts, which predict the availability or onset of a drug effect, can acquire conditioned incentive motivational properties. These conditioned properties endure after withdrawal, and can promote drug-seeking which may result in relapse. Conditioned place preference (CPP) assesses the associations between drugs and the context in which they are experienced. Here, we review the potential utility of CPP procedures in rodents and humans to evaluate medications that target conditioned drug-seeking responses. We discuss the translational potential of the CPP procedure from rodents to humans, and review findings with FDA-approved treatments that support the use of CPP to develop relapse-reduction medications. We also discuss challenges and methodological questions in applying the CPP procedure to this purpose. We argue that an efficient and valid CPP procedure in humans may reduce the burden of full clinical trials with drug-abusing patients that are currently required for testing promising treatments.

Indexed as

AnimalsAntidepressive Agents, TricyclicBehavior, AnimalCentral Nervous System StimulantsConditioning, PsychologicalHumansMotivationSecondary PreventionAntidepressive Agents, TricyclicCentral Nervous System StimulantsAddiction therapyAmphetamineBaclofenConditioned place preferenceHumansMethamphetamineMirtazapineNaltrexoneRodentsVarenicline

Identifiers

PMID23680702
PMCPMC3815959

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.